Skip to main content
Premium Trial:

Request an Annual Quote

Already Left Out

UK researchers are already feeling the effects of the so-called Brexit referendum last month in which the UK voted to leave the European Union, the Guardian's Ian Sample reports.

A survey conducted by the Guardian of Russell Group universities — 24 public research universities in the UK — found that some British researchers have been asked to step down from leadership positions of EU-funded projects or leave projects all together, Sample writes. He notes that UK researchers are "considered a financial liability."

While some universities surveyed noted anecdotal claims that UK researchers were being left off EU projects shortly after the vote, they've since seen harder evidence, the Guardian says. This is something UK researchers feared would occur in the aftermath of the vote.

For instance, Sample reports that a EU project officer recommended that UK partners be taken off a consortium since the UK's funding contribution wasn't assured, and if the UK partners remained on the project, the officer cautioned that the project, which has a projected January 2017 start date, would have be pushed back until the UK has a new deal in place with Europe. 

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.